20 LATEST RESOURCES (686 INDEXED)
×
Pimavanserin Treatment of Hallucinations and Delusions in Patients with Parkinson’s Disease Dementia: Post Hoc Analysis of the HARMONY Trial (Meetings-Events) · May 2022
Abstracts
Neurology
×
Efficacy of Music Therapy and Predictors of Sleep Disturbance among Patients with Chronic Schizophrenia: A Prospective Study · April 2022
Abstracts
Archives of Psychiatric Nursing
×
The Efficacy of Nutritional Supplements for the Adjunctive Treatment of Schizophrenia in Adults: A Systematic Review and Network Meta-Analysis · March 2022
Abstracts
Psychiatry Research
×
Real-World Effectiveness of Antipsychotic Doses for Relapse Prevention in Patients with First-Episode Schizophrenia in Finland: A Nationwide, Register-Based Cohort Study · February 2022
Abstracts
Lancet Psychiatry
×
Efficacy of a Gluten-Restricted Diet in Treatment-Resistant Schizophrenia Patients with Immunological Gluten Sensitivity: A Case Report · January 2022
Abstracts
Schizophrenia Research
×
Effect of Emotional Awareness Skills Training on Emotional Awareness and Communication Skills in Patients with Schizophrenia: A Randomized Controlled Trial · January 2022
Abstracts
Archives of Psychiatric Nursing
×
Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents with Psychosis Treated with Aripiprazole or Quetiapine: Results from the TEA Trial · January 2022
Abstracts
Journal of the American Academy of Child and Adolescent Psychiatry
×
Video Self-Confrontation as a Therapeutic Tool in Schizophrenia: A Randomized Parallel-Arm Single-Blind Trial · January 2022
Abstracts
Schizophrenia Research
×
Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents from 15 Countries: A Systematic Review and Meta-Analysis · December 2021
Abstracts
JAMA Psychiatry
×
Antipsychotics for Agitation and Psychosis in People with Alzheimer’s Disease and Vascular Dementia · December 2021
Abstracts
Cochrane Database of Systematic Reviews
×
Pimavanserin for Negative Symptoms of Schizophrenia: Results from the Advance Phase 2 Randomised, Placebo-Controlled Trial in North America and Europe · November 2021
Abstracts
Lancet Psychiatry
×
Associations between Plasma Fatty Acid Concentrations and Schizophrenia: A Two-Sample Mendelian Randomisation Study · November 2021
Abstracts
Lancet Psychiatry
×
Parenting Interventions for People with Schizophrenia or Related Serious Mental Illness · October 2021
Abstracts
Cochrane Database of Systematic Reviews
×
Humour‐Based Interventions for People with Schizophrenia · October 2021
Abstracts
Cochrane Database of Systematic Reviews
×
The Association of Plasma Inflammatory Markers with Omega-3 Fatty Acids and Their Mediating Role in Psychotic Symptoms and Functioning: An Analysis of the NEURAPRO Clinical Trial · October 2021
Abstracts
Brain, Behavior, and Immunity
×
Differences in the Incidence of Lurasidone Adverse Events between Depressive Disorders and Schizophrenia in Double-Blind, Randomized, Placebo-Controlled Trials: A Meta-Analysis · September 2021
Abstracts
Psychopharmacology
×
Antipsychotic Use and Risk of Breast Cancer in Women with Schizophrenia: A Nationwide Nested Case-Control Study in Finland · August 2021
Abstracts
Lancet Psychiatry
×
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients with Stable Schizophrenia: A Meta-Analysis · August 2021
Abstracts
JAMA Psychiatry
×
Relationship of Prolactin Concentrations to Steady-State Plasma Concentrations of Aripiprazole in Patients with Schizophrenia · August 2021
Abstracts
Therapeutic Drug Monitoring
×
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Psychosis · August 2021
Abstracts
Substance Use and Misuse